SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-22-000788
Filing Date
2022-06-24
Accepted
2022-06-24 16:37:58
Documents
16
Period of Report
2022-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k-atm.htm   iXBRL 8-K 28890
2 EXHIBIT 5.1 ex5x1.htm EX-5.1 8236
3 AT THE MARKET OFFERING AGREEMENT, DATED JUNE 24, 2022, BY AND AMONG OPGEN, INC. ex1x1.htm EX-1.1 208385
7 GRAPHIC image_001.jpg GRAPHIC 2121
8 GRAPHIC image_002.jpg GRAPHIC 3313
  Complete submission text file 0001079973-22-000788.txt   480116

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20220617.xsd EX-101.SCH 2950
5 XBRL LABEL FILE opgn-20220617_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE opgn-20220617_pre.xml EX-101.PRE 22353
10 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k-atm_htm.xml XML 3563
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 221040615
SIC: 8071 Services-Medical Laboratories